Zhe Gao

Effect of glucagon‐like peptide‐1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta‐analysis

Xiu-Fang Lv, Xiaolu Yan, Kaixin Duan, 2022, Journal of diabetes investigation.

Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice

L. Ren, Shuchun Chen, Liying Yang, 2022, Bioengineered.

β-catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet

L. Ren, G. Song, Shuchun Chen, 2020, European journal of histochemistry : EJH.

Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Yichao Wang, Lijing Huo, L. Ren, 2022, International journal of general medicine.

Comparing the effectiveness of long-term use of daily and weekly glucagon-like peptide-1 receptor agonists treatments in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus: a network meta-analysis

L. Ren, X. Yuan, Kaixin Duan, 2023, Frontiers in Endocrinology.

Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head meta-analysis

Kaixin Duan, Zhe Gao, Caixuan Yang, 2023, Medicine.